Registry of Patients Treated With Systemic Mold-Active Tr... | NCT03066011 | Trialant

Registry of Patients Treated With Systemic Mold-Active Tr... | NCT03066011 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Isavuconazonium sulfate Group		Oral and Intravenous	Drug: Isavuconazonium sulfate
Voriconazole Group		Oral and Intravenous	Drug: Voriconazole
Posaconazole Group		Oral and Intravenous	Drug: Posaconazole

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Treatment patterns of care assessed by reason for therapy	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by category of diagnosis at time of therapy initiation	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by onset of treatment/prophylaxis	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by length of treatment/prophylaxis	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by use of diagnostic method(s)	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by type of diagnostic method(s) used	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.	5 years
Treatment patterns of care assessed by use of therapeutic drug monitoring (TDM)	Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.

Secondary Outcomes

Measure	Description	Time Frame
Overall healthcare resource utilization assessed by hospitalization length of stay (LOS)	Assessments of overall healthcare resource inpatient utilization will be summarized	5 years
Overall healthcare resource utilization assessed by time spent in Intensive Care Unit (ICU)

Contacts/Locations Module